Investor Stock List
Ranked #2,238 of 8,699 institutional investors

MPM Bioimpact LLC

Boston, MA

$1.09B
US stock portfolio at live prices · today −$8.4M (−0.76%)
Market closed. Prices as of Nov 20, 6:11 AM ET
Value at quarter end (Q3 2026)
$1.30B
Change from Q2 2026
−$340.9M (−20.79%)
Positions
33 · 9 new, 9 sold out
Filed
Nov 16, 2026

Not counted in the ranking: put options on $48.6M. $84.5M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
CGEM 8.09%AKTS 7.27%LQDA 6.97%EWTX 5.95%TVTX 4.82%
StockSharesValue, live% of portfoliovs Q2 2026
CGEM Cullinan Therapeutics, Inc.9,721,081$88.2M8.09%Reduced −0%
AKTS Aktis Oncology, Inc.4,835,872$79.3M7.27%Unchanged
LQDA Liquidia Corporation1,342,713$76.0M6.97%Reduced −3%
EWTX Edgewise Therapeutics, Inc.1,575,987$64.9M5.95%Reduced −3%
TVTX Travere Therapeutics, Inc.1,088,363$52.6M4.82%Reduced −3%
DYN Dyne Therapeutics, Inc.3,208,146$51.4M4.72%Added +67%
TRVI Trevi Therapeutics, Inc.2,978,906$40.9M3.75%Reduced −3%
RLAY Relay Therapeutics, Inc.2,369,578$37.7M3.46%Reduced −2%
IMCR Immunocore Holdings plc1,203,289$32.0M2.94%New
ORKA Oruka Therapeutics, Inc.300,000$29.3M2.68%New
PVLA Palvella Therapeutics, Inc.197,633$28.8M2.64%Reduced −3%
DBVT DBV Technologies S.A.3,044,659$28.7M2.63%Reduced −17%
CORT Corcept Therapeutics Incorporated422,000$27.4M2.51%Reduced −45%
TARS Tarsus Pharmaceuticals, Inc.352,676$27.4M2.51%Added +10%
TSHA Taysha Gene Therapies, Inc.7,262,959$27.4M2.51%Added +61%
ABVX ABIVAX Société Anonyme328,379$26.5M2.43%Reduced −2%
VSTM Verastem, Inc.3,851,604$26.4M2.42%New
NTRA Natera, Inc.90,585$26.3M2.41%Reduced −2%
VIR Vir Biotechnology, Inc.2,809,711$24.9M2.29%New
STOK Stoke Therapeutics, Inc.925,133$24.9M2.28%Added +28%
ODTX Odyssey Therapeutics, Inc.1,289,091$23.6M2.17%New
IOVA Iovance Biotherapeutics, Inc.2,835,734$20.7M1.90%New
BLTE Belite Bio, Inc133,387$20.1M1.85%Reduced −3%
ACRS Aclaris Therapeutics, Inc.5,178,127$18.1M1.66%Added +397%
ANL Adlai Nortye Group Ltd.1,956,618$17.7M1.63%Added +1%
NGNE Neurogene Inc.771,839$17.7M1.62%New
ANNX Annexon, Inc.4,290,616$14.6M1.34%Added +21%
ORIC ORIC Pharmaceuticals, Inc.1,821,951$14.0M1.29%Reduced −3%
TRAX First Tracks Biotherapeutics, Inc.254,374$11.3M1.04%New
GLUE Monte Rosa Therapeutics, Inc.1,125,216$10.0M0.92%Reduced −3%
BIOA BioAge Labs, Inc.1,856,748$8.7M0.80%Added +11%
CRBP Corbus Pharmaceuticals Holdings, Inc.1,667,272$4.1M0.37%New
DRUG Bright Minds Biosciences Inc.195,669$4.1M0.37%Reduced −3%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
RVMD Revolution Medicines, Inc.492,483$78.5M
DNTH Dianthus Therapeutics, Inc.420,002$35.6M
RARE Ultragenyx Pharmaceutical Inc.1,418,215$24.4M
MLTX MoonLake Immunotherapeutics1,606,967$17.7M
SNDX Syndax Pharmaceuticals, Inc.1,333,523$12.2M
ALMS Alumis Inc.2,019,020$8.7M
TRDA Entrada Therapeutics, Inc.1,253,053$5.8M
CNTX Context Therapeutics Inc.1,299,046$219K
HOWL Werewolf Therapeutics, Inc.80,142$79K